In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fragrance or foolery: 15 big drug events will resolve before April

This article was originally published in Scrip

Executive Summary

There are 15 big drug development decisions to be taken before April 1, seven of those in the hands of regulatory agencies in the US and Europe. The rest are dependent on clinical data, and some of the companies involved almost certainly already know which way the results going. All of which leaves 14 companies' senior management teams (Sanofi's has two clinical trials to ponder) wondering whether they will feel like bunches of April flowers, or bunches of fools.



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts